News & Events

January 01, 2017

VIDAC PHARMA APPOINTS CHIEF MEDICAL AND CHIEF SCIENCE OFFICERS

Jerusalem, Israel, January 1, 2017 – Vidac Pharma, a clinical-stage oncology-focused pharmaceutical company, today announced the appointment of Dr. Chaim Brickman as the company's Chief Medical Officer, and the appointment of Dr. Vered Behar as the company's…
December 12, 2016

VIDAC PHARMA PHASE 2 STUDY OF VDA-1102 IN ACTINIC KERATOSIS MEETS INTERIM ANALYSIS CRITERION

Jerusalem, Israel, December 12, 2016 – Vidac Pharma, a clinical-stage oncology-focused pharmaceutical company, today announced that the ongoing Phase 2 study with VDA-1102 ointment, a potent selective VDAC/HK2 modulator, in actinic keratosis (AK) met a…
July 29, 2016

VIDAC PHARMA ANNOUNCES THE INNITIATION OF A PHASE 2 STUDY OF VDA-1102 OINTMENT IN PATIENTS WITH ACTINIC KERATOSIS

Jerusalem, Israel, July 29, 2016 – Vidac Pharma, a clinical stage oncology focused pharmaceutical company, today announced that the Company has initiated a Phase 2 trial with VDA-1102 ointment, a potent selective VDAC/HK2 modulator, to treat subjects with…
June 30, 2016

VIDAC PHARMA COMPLETES PHASE 1A TRIAL OF VDA-1102 OINTMENT

Jerusalem, Israel, June 30, 2016 – Vidac Pharma, a clinical stage oncology focused pharmaceutical company, today announced that the Company has completed a Phase 1a trial of VDA-1102 ointment, a topical ointment formulation of VDA-1102, a potent selective…
Jun 29, 2016

Vidac Pharma Completes $9 Million Series A Financing I Advances Phase 2 Studies with VDA-1102 In Actinic Keratosis

Jerusalem, Israel, June 29, 2016 – Vidac Pharma, a privately-held clinical stage…
Feb 25, 2016

Vidac Pharma Initiates Phase I Clinical Trial With Its Novel VDAC/HK2 Modulator

Jerusalem, Israel, February 25, 2016 – Vidac Pharma, a clinical stage drug development…
Dec 30, 2015

Vidac Pharma Announces Filing of IND with U.S. FDA for Development of VDA-1102 for Treatment of Actinic Keratosis

Jerusalem, Israel, December 30, 2015 – Vidac Pharma, a drug discovery and development…
Oct 15, 2014

Vidac Pharma Appoints Dr. Chaim Brickman as Vice President of Clinical Affairs

Jerusalem, Israel, November 15, 2014 – Vidac Pharma, a drug discovery and development…
Aug 19, 2014

Vidac Pharma Appoints Dr. Paul Salama as Vice President of Chemistry, Manufacturing, and Control

Ness Ziona, Israel, August 19, 2014 – Vidac Pharma, a drug discovery and development…

 

back Factsheet